Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (25)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Laird, S.M.
Right arrow Articles by Li, T.C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laird, S.M.
Right arrow Articles by Li, T.C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Molecular Human Reproduction, Vol. 6, No. 1, 34-40, January 2000
© 2000 European Society of Human Reproduction and Embryology


Uterus and pregnancy

Expression of nuclear factor {kappa} B in human endometrium; role in the control of interleukin 6 and leukaemia inhibitory factor production

S.M. Laird1,2,3, E.M. Tuckerman2, B.A. Cork1 and T.C. Li2

1 Biomedical Research Centre, Division of Biomedical Sciences, Sheffield Hallam University, City Campus, Sheffield S1 1WB and 2 Biomedical Research Unit, Jessop Hospital for Women, Leavygreave Rd. Sheffield S3 7RE, UK

Abstract

Expression of the rel-A component of nuclear factor {kappa} B (NF{kappa}B) by human endometrial cells was investigated by immunocytochemical analysis of cryostat sections cut from endometrial biopsy material and of cultured endometrial epithelial cells. In-vivo expression of rel-A was low in epithelial cells in endometrium obtained during the proliferative phase of the cycle, but increased in these cells during the secretory phase and was maximal at the time of implantation. In-vivo expression of rel-A by stromal cells did not vary greatly throughout the cycle, but showed a slight peak at the time of ovulation. In contrast similar expression of rel-A was seen in short-term cultures of epithelial cells prepared from both proliferative and secretory endometrium. Addition of the NF{kappa}B inhibitor SN50 (5 µg/ml) to confluent cultures of endometrial epithelial cells inhibited interleukin (IL)-1{alpha} (10 ng/ml) and tumour necrosis factor {alpha} (TNF{alpha}) (10 ng/ml) stimulated IL-6 (P < 0.001 and P < 0.01 respectively) and LIF (P < 0.01 and P < 0.05 respectively) production. The proteasome inhibitor MG132 (0.3 and 3 µmol/l) also caused a dose-dependent decrease in IL-1{alpha} and TNF{alpha}-stimulated IL-6 (P < 0.001 and P < 0.001 respectively) and leukaemia inhibitory factor (LIF) (P < 0.001 and P < 0.001 respectively) production by endometrial epithelial cells. The results support the hypothesis that NF{kappa}B mediates signalling between IL-1 and TNF{alpha} receptors and the expression of LIF and IL-6 in endometrial epithelial cells.

cytokines/endometrium/human/NF{kappa}B

Notes

3 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
ReproductionHome page
C. Ponce, M. Torres, C. Galleguillos, H. Sovino, M A. Boric, A. Fuentes, and M C. Johnson
Nuclear factor {kappa}B pathway and interleukin-6 are affected in eutopic endometrium of women with endometriosis
Reproduction, April 1, 2009; 137(4): 727 - 737.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
J. S. Fitzgerald, T. G. Poehlmann, E. Schleussner, and U. R. Markert
Trophoblast invasion: the role of intracellular cytokine signalling via signal transducer and activator of transcription 3 (STAT3)
Hum. Reprod. Update, April 17, 2008; (2008) dmn010v1.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
R. Gonzalez-Ramos, J. Donnez, S. Defrere, I. Leclercq, J. Squifflet, J.-C. Lousse, and A. Van Langendonckt
Nuclear factor-kappa B is constitutively activated in peritoneal endometriosis
Mol. Hum. Reprod., July 1, 2007; 13(7): 503 - 509.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Wieser, J.-L. Vigne, I. Ryan, D. Hornung, S. Djalali, and R. N. Taylor
Sulindac Suppresses Nuclear Factor-{kappa}B Activation and RANTES Gene and Protein Expression in Endometrial Stromal Cells from Women with Endometriosis
J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6441 - 6447.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
S. J Kimber
Leukaemia inhibitory factor in implantation and uterine biology
Reproduction, August 1, 2005; 130(2): 131 - 145.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Sugino, A. Karube-Harada, A. Sakata, S. Takiguchi, and H. Kato
Nuclear Factor-{kappa}B Is Required for Tumor Necrosis Factor-{alpha}-Induced Manganese Superoxide Dismutase Expression in Human Endometrial Stromal Cells
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3845 - 3850.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
A. E. King, H. O.D. Critchley, and R. W. Kelly
The NF-{{kappa}}B pathway in human endometrium and first trimester decidua
Mol. Hum. Reprod., February 1, 2001; 7(2): 175 - 183.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
S. Pampfer, S. Cordi, S. Cikos, B. Picry, I. Vanderheyden, and R. D. Hertogh
Activation of Nuclear Factor {kappa}B and Induction of Apoptosis by Tumor Necrosis Factor-{alpha} in the Mouse Uterine Epithelial WEG-1 Cell Line
Biol Reprod, September 1, 2000; 63(3): 879 - 886.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.